found that expression of a tetracycline regulatable Combi-tTA-Snai1 transgene was able to induce tumor development in mice from 5 months onwards, with 40% of tumor being AML and 50% being lymphomas (152). This evidence concerns the gene SNAI1 and acute myeloid leukemia.